Biblio Discovery — Demo Discovery Service

59 results for "P. Chavda"

Showing 1–20 · 0.69 seconds · RSS

  1. Journal Article Full text

    Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?

    Vivek P. Chavda; Vasso Apostolopoulos

    Vaccines, Vol. 10 No. 3 · 2022 · English · DOAJ Scopus

    The Omicron variant of SARS-CoV-2 is emerging in communities where people were previously infected with SARS-CoV-2 and are now being vaccinated, or where many people have received two or three coronavirus vaccination doses. More than 130 countries around the globe have implemented booster dose…

  2. Journal Article Full text

    SARS-CoV-2: Immunopeptidomics and Other Immunological Studies

    Vivek P. Chavda; Elrashdy M. Redwan

    Vaccines, Vol. 10 No. 11 · 2022 · English · DOAJ Scopus

    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has produced a significant continuing epidemic worldwide [...]

  3. Journal Article Full text

    A Bead Aggregation Assay for Detection of Low-Affinity Protein-Protein Interactions Reveals Interactions between N-Terminal Domains of Inositol 1,4,5-Trisphosphate Receptors

    Alap P. Chavda; David L. Prole; Colin W. Taylor

    PLoS ONE, Vol. 8 No. 3 · 2013 · English · PLOS Scopus

    Interactions between proteins are a hallmark of all cellular activities. Such interactions often occur with low affinity, a feature that allows them to be rapidly reversible, but it makes them difficult to detect using conventional methods such as yeast 2-hybrid analyses, co-immunoprecipitation or…

    Also available at: DOAJ

  4. Journal Article Full text

    A Veterinary Vaccine for SARS-CoV-2: The First COVID-19 Vaccine for Animals

    Vivek P Chavda; Jack Feehan; Vasso Apostolopoulos

    Vaccines, Vol. 9 No. 6 · 2021 · English · DOAJ Scopus

    As coronaviruses have a wide range of host species, many animals harbor these pathogens, however only a handful of them become severely infected [...]

  5. Journal Article Full text

    Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

    Vivek P. Chavda; Toshika Mishra; Suneetha Vuppu

    Vaccines, Vol. 11 No. 1 · 2022 · English · DOAJ Scopus

    The zoonotic SARS-CoV-2 virus was present before the onset of the pandemic. It undergoes evolution, adaptation, and selection to develop variants that gain high transmission rates and virulence, resulting in the pandemic. Structurally, the spike protein of the virus is required for binding to ACE2…

  6. Journal Article Full text

    Inflammation: The Cause of All Diseases

    Vivek P. Chavda; Jack Feehan; Vasso Apostolopoulos

    Cells, Vol. 13 No. 22 · 2024 · English · DOAJ Scopus

    Inflammation is an essential biological process that serves as the body’s first line of defence against harmful stimuli, including pathogens, damaged cells, and irritants [...]

  7. Journal Article Full text

    Inhalable Vaccines: Can They Help Control Pandemics?

    Vivek P. Chavda; Lalitkumar K. Vora; Vasso Apostolopoulos

    Vaccines, Vol. 10 No. 8 · 2022 · English · DOAJ Scopus

    The emergence of a new coronavirus presents a huge risk to public health worldwide and has spread widely amongst the human population. Since its emergence, the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is frequently evolving by mutation and genetic recombination to give rise to…

  8. Journal Article

    Therapeutics for COVID-19 and post COVID-19 complications: An update

    Debdoot Basu; Vivek P. Chavda; Anita A. Mehta

    Current Research in Pharmacology and Drug Discovery, Vol. 3 · 2022 · English · DOAJ Scopus

    Since its inception in late December 2020 in China, novel coronavirus has affected the global socio-economic aspect. Currently, the world is seeking safe and effective treatment measures against COVID-19 to eradicate it. Many established drug molecules are tested against SARS-CoV-2 as a part of…

  9. Journal Article Full text

    Aged Population and Immunocompromised Patients: Impact on SARS-CoV-2 Variants and Treatment Outcomes

    Vivek P. Chavda; Mahesh T. Chhabria; Vasso Apostolopoulos

    Biologics, Vol. 2 No. 3 · 2022 · English · DOAJ Scopus

    Patients with an immunocompromised state are at risk of developing a long-term infection from the coronavirus 2 that causes severe acute respiratory syndrome (SARS-CoV-2) [...]

  10. Journal Article Full text

    An Impact of COVID-19 on Cancer Care: An Update

    Vivek P. Chavda; Feng-Feng Ping; Zhe-Sheng Chen

    Vaccines, Vol. 10 No. 12 · 2022 · English · DOAJ Scopus

    The world has been affected socioeconomically for the last two years due to the emergence of different variants of the COVID-19 virus. Vaccination is the major and most efficient way to prevent the widening of this pandemic. Those who are having comorbidities are more vulnerable to serious…

  11. Journal Article Full text

    The Emergence of Hybrid Variants of SARS-CoV-2: Towards Hybrid Immunity

    Vivek P. Chavda; Suneetha Vuppu; Toshika Mishra et al.

    Vaccines, Vol. 11 No. 4 · 2023 · English · DOAJ Scopus

    In this review work, the authors emphasize the discussion on different emerging variants of SARS-CoV-2 and vaccine effectiveness against them [...]

  12. Journal Article Full text

    Nucleic Acid Vaccines for COVID-19: A Paradigm Shift in the Vaccine Development Arena

    Vivek P. Chavda; Md Kamal Hossain; Jayesh Beladiya et al.

    Biologics, Vol. 1 No. 3 · 2021 · English · DOAJ Scopus

    Coronavirus disease, COVID-19, has touched every country globally except five countries (North Korea, Turkmenistan, Tonga, Tuvalu and Nauru). Vaccination is the most effective method to protect against infectious diseases. The objective is to ensure that everyone has access to a COVID-19 vaccine…

  13. Journal Article

    Darunavir ethanolate: Repurposing an anti-HIV drug in COVID-19 treatment

    Vivek P. Chavda; Normi Gajjar; Nirav Shah et al.

    European Journal of Medicinal Chemistry Reports, Vol. 3 · 2021 · English · DOAJ Scopus

    Antivirals already on the market and expertise gained from the SARS and MERS outbreaks are gaining momentum as the most effective way to combat the coronavirus outbreak. SARS-CoV-2 has caused considerable mortality due to respiratory failure, highlighting the immediate need for successful therapies…

  14. Journal Article Full text

    A Review on the Impact of the SARS-CoV-2 Omicron Subvariant on Elderly Patients with Diverse Co-Morbidities

    Avinash Khadela; Shruti Soni; Kaivalya Megha et al.

    Biologics, Vol. 3 No. 2 · 2023 · English · DOAJ Scopus

    The SARS-CoV-2 virus has caused a catastrophic impact on the world for the past 3 years. The virus has now returned with the emergence of the Omicron (B.1.1.529) variant. Within two months of its first emergence in South Africa, Omicron became the most dominating SARS-CoV-2 variant around the…

  15. Journal Article Full text

    The Delta and Omicron Variants of SARS-CoV-2: What We Know So Far

    Vivek P. Chavda; Rajashri Bezbaruah; Kangkan Deka et al.

    Vaccines, Vol. 10 No. 11 · 2022 · English · DOAJ Scopus

    The world has not yet completely overcome the fear of the havoc brought by SARS-CoV-2. The virus has undergone several mutations since its initial appearance in China in December 2019. Several variations (i.e., B.1.616.1 (Kappa variant), B.1.617.2 (Delta variant), B.1.617.3, and BA.2.75 (Omicron…

  16. Journal Article Full text

    The Vaccine World of COVID-19: India’s Contribution

    Vivek P. Chavda; Disha R. Vihol; Hetvi K. Solanki et al.

    Vaccines, Vol. 10 No. 11 · 2022 · English · DOAJ Scopus

    The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) eruption has left not only illness and mortality in its wake, but also an overwhelming threat to health policy, human regality, food security, and struggle worldwide. The accessibility and potential distribution of a protective and…

  17. Journal Article Full text

    Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review

    Vivek P. Chavda; Jinal Ajabiya; Divya Teli et al.

    Molecules, Vol. 27 No. 13 · 2022 · English · DOAJ Scopus

    The prevalence of obesity and diabetes is an increasing global problem, especially in developed countries, and is referred to as the twin epidemics. As such, advanced treatment approaches are needed. Tirzepatide, known as a ‘twincretin’, is a ‘first-in-class’ and the only dual glucagon-like…

  18. Journal Article

    Phytochemical Delivery Through Transferosome (Phytosome): An Advanced Transdermal Drug Delivery for Complementary Medicines

    Rong-Ping Chen; Vivek P. Chavda; Aayushi B. Patel et al.

    Frontiers in Pharmacology, Vol. 13 · 2022 · English · DOAJ Scopus

    Transdermal drug delivery aims to create a safe and effective method of administering drugs through the skin that attracts a lot of attention and investment due to the constant progress in the field. Transferosomes are flexible or malleable vesicles (having almost the same structure as liposomes…